JPMORGAN CHASE & CO

Holdings History for ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA)

Symbol: ZVRA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$3,693,858	412,261	-26,723	-6.1%	$8.96	Q4 2025
30 Sep 2025	0%	+0%	$4,174,739	438,984	+410,823	+1459%	$9.51	Q3 2025
30 Jun 2025	0%	-0%	$248,099	28,161	-977	-3.4%	$8.81	Q2 2025
31 Mar 2025	0%	+0%	$218,243	29,138	+1,648		$7.49	Q1 2025
31 Dec 2024	0%	+0%	$229,267	27,490	+9,225	+51%	$8.34	Q4 2024
30 Sep 2024	0%	0%	$126,759	18,265	-400	-2.1%	$6.94	Q3 2024
30 Jun 2024	0%	+0%	$91,458	18,665	+3,604	+24%	$4.90	Q2 2024
31 Mar 2024	0%	-0%	$87,354	15,061	-11,833	-44%	$5.80	Q1 2024
31 Dec 2023	0%	+0%	$176,156	26,894	+3,631	+16%	$6.55	Q4 2023
30 Sep 2023	0%	-0%	$112,128	23,263	-4,411	-16%	$4.82	Q3 2023
30 Jun 2023	0%	+0%	$141,138	27,674	+26,896	+3457%	$5.10	Q2 2023
31 Mar 2023	0%	0%	$4,000	778	0		$5.14	Q1 2023
31 Dec 2022	0%	-0%	$4,000	778	-1,397	-64%	$5.14	Q4 2022
30 Sep 2022	0%	+0%	$14,000	2,175	+613	+39%	$6.44	Q3 2022
30 Jun 2022	0%	-0%	$7,000	1,562	-16,533	-91%	$4.48	Q2 2022
31 Mar 2022	0%	+0%	$91,000	18,095	+3,990	+28%	$5.03	Q1 2022
31 Dec 2021	0%	-0%	$123,000	14,105	-718	-4.8%	$8.72	Q4 2021
30 Sep 2021	0%	+0%	$138,000	14,823	+3,851	+35%	$9.31	Q3 2021
30 Jun 2021	0%	+0%	$141,000	10,972	+10,972	NEW	$12.85	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.